Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8968742
SERIAL NO

13975214

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antibody drug conjugates (ADC's) that bind to 158P1D7 protein and variants thereof are described herein. 158P1D7 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in glioblastoma, lung cancer, bladder cancer, and breast cancer. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SEAGEN INC21823 30TH DRIVE S E BOTHELL WA 98021

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
An, Zili Santa Monica, US 23 118
Jia, Xiao-Chi Los Angeles, US 78 1901
Morrison, Karen Jane Meyrick Santa Monica, US 90 604
Morrison, Robert Kendall Santa Monica, US 90 568
Snyder, Josh Santa Monica, US 12 29

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 3, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00